Project Grant R61DA061327
- This $882,816 Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) will support research by Rutgers, The State University to advance patient-centered treatment for co-occurring post-traumatic stress disorder (PTSD) and substance use disorder (SUD). The project will use meta-analysis of individual patient data, integrative data analysis, and propensity score weighting to evaluate the comparative efficacy of pharmacological,...
- This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop and evaluate an adapted version of Written Exposure Therapy (WET) for treating posttraumatic stress disorder (PTSD) among individuals with opioid use disorder (OUD) in residential substance use disorder (SUD) treatment settings. The $798,605 award will fund a multi-site study to create and test the adapted "Written Exposure in...
- This Project Grant award, provided by the National Institute of Mental Health (CFDA 93.242 Mental Health Research Grants), supports the development of an adaptive intervention to improve access, engagement, and effectiveness of posttraumatic stress disorder (PTSD) treatment in routine care settings. The $939,784 award to Boston Medical Center Corporation aims to sequence a digital behavioral health intervention and brief trauma- and skills-focused treatments for PTSD. The selected treatments are...
- This Project Grant award of $2,384,097, provided by the Defense Health Agency through the Military Medical Research and Development (CFDA 12.420) federal grant program, is funding a hybrid experimental clinical trial to determine the optimal sequencing of interventions to maximize the effectiveness of PTSD treatment. The primary awardee, The University of Texas Health Science Center at San Antonio, will conduct this research with a planned completion date of August 2028. The project involves two...
- This federal Project Grant award of $459,045, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), is for a study titled "The Cascade of Care for Patients with Opioid Use Disorder Identified Through a Large Public Health System." The study aims to modify the existing Opioid Use Disorder (OUD) Cascade of Care model to better reflect the changing landscape of real-world OUD treatment, enabling critical research...
- The National Institute on Drug Abuse (NIDA) awarded a $2,729,018 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Rhode Island. The purpose of this 2-year award, with a start date of September 15, 2024, is to rigorously develop and evaluate a mobile health intervention for adults with co-occurring opioid use disorder (OUD) and post-traumatic stress disorder (PTSD) during community re-entry after residential OUD treatment. The proposed mobile app...
- This federal Project Grant award of $158,246.00 from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, will support research under the Drug Use and Addiction Research Programs (CFDA 93.279). The award will fund a comprehensive, longitudinal study investigating the co-occurrence of trauma, substance use, and additional stressors among Americans from childhood through adulthood. The research aims to elucidate the etiological trajectories of co-occurring...
- The Defense Health Agency has awarded a $1.632 million Project Grant to the Ocean State Research Institute, Inc., a non-profit research organization, to investigate the long-term outcomes of antipsychotic medication use in U.S. veterans with post-traumatic stress disorder (PTSD). This grant, funded through the Military Medical Research and Development program (CFDA 12.420), supports basic, applied, and advanced biomedical research to transform healthcare for service members and the public. As...
- This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is intended to develop and evaluate an adaptive psychological intervention to improve pain management and reduce opioid use following an injury. The $264,995 grant, awarded on September 15, 2025, will fund the optimization and feasibility testing of a two-part intervention. The first part is a 15-minute computerized brief intervention focused on...
- This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will fund a research project titled "AUGMENTING COGNITIVE PROCESSING THERAPY WITH A PEER-LED SUPPORT INTERVENTION TO IMPROVE WELL-BEING: A SUSTAINABLE AND SCALABLE MODEL FOR ENHANCING PTSD RECOVERY IN VULNERABLE POPULATIONS." The $567,000 award to Trustees of Boston University's Medical Campus will support the development and evaluation of a model...
This federal Project Grant award of $408,679 was provided by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), under the Drug Use and Addiction Research Programs (CFDA 93.279). The goal of the project is to develop a scalable, equitable, and optimal adaptive treatment strategy for patients with co-occurring opioid use disorder (OUD) and post-traumatic stress disorder (PTSD). The key products or services to be delivered under this 2-year award include: The project is a collaborative effort led by the RAND Corporation, along with partners from the University of New Mexico, Stanford University, Boston University, and the New Mexico Office of Community Health Workers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 9/8/25 | ||
| Not listed | $408.7k | 8/27/25 |